207 related articles for article (PubMed ID: 12524047)
1. Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans.
Warda M; Mao W; Toida T; Linhardt RJ
Comp Biochem Physiol B Biochem Mol Biol; 2003 Jan; 134(1):189-97. PubMed ID: 12524047
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of raw heparin from dromedary intestine: evaluation of a new source of pharmaceutical heparin.
Warda M; Gouda EM; Toida T; Chi L; Linhardt RJ
Comp Biochem Physiol C Toxicol Pharmacol; 2003 Dec; 136(4):357-65. PubMed ID: 15012907
[TBL] [Abstract][Full Text] [Related]
3. Surprising absence of heparin in the intestinal mucosa of baby pigs.
Yu Y; Chen Y; Mikael P; Zhang F; Stalcup AM; German R; Gould F; Ohlemacher J; Zhang H; Linhardt RJ
Glycobiology; 2017 Jan; 27(1):57-63. PubMed ID: 27744271
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of low molecular weight glycosaminoglycans from marine mollusc Amussium pleuronectus (linne) using chromatography.
Saravanan R; Shanmugam A
Appl Biochem Biotechnol; 2010 Mar; 160(3):791-9. PubMed ID: 19184547
[TBL] [Abstract][Full Text] [Related]
5. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
[TBL] [Abstract][Full Text] [Related]
6. Chemoenzymatic Synthesis of Glycosaminoglycans.
Zhang X; Lin L; Huang H; Linhardt RJ
Acc Chem Res; 2020 Feb; 53(2):335-346. PubMed ID: 31714740
[TBL] [Abstract][Full Text] [Related]
7. Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate.
Warda M; Linhardt RJ
Comp Biochem Physiol B Biochem Mol Biol; 2006 Jan; 143(1):37-43. PubMed ID: 16298150
[TBL] [Abstract][Full Text] [Related]
8. Heparin induces changes in the synthesis of porcine aortic endothelial cell heparan sulfate proteoglycans.
Morrison P; Lowe-Krentz LJ
Exp Cell Res; 1989 Oct; 184(2):304-15. PubMed ID: 2530099
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the interaction between Robo1 and heparin and other glycosaminoglycans.
Zhang F; Moniz HA; Walcott B; Moremen KW; Linhardt RJ; Wang L
Biochimie; 2013 Dec; 95(12):2345-53. PubMed ID: 23994753
[TBL] [Abstract][Full Text] [Related]
10. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
Graham LD; Whitelock JM; Underwood PA
Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
[TBL] [Abstract][Full Text] [Related]
11. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding.
Herndon ME; Stipp CS; Lander AD
Glycobiology; 1999 Feb; 9(2):143-55. PubMed ID: 9949192
[TBL] [Abstract][Full Text] [Related]
12. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.
Klein DJ; Oegema TR; Brown DM
Diabetes; 1989 Jan; 38(1):130-9. PubMed ID: 2521210
[TBL] [Abstract][Full Text] [Related]
13. Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparan sulfate proteoglycans.
Brandan E; Maldonado M; Garrido J; Inestrosa NC
J Cell Biol; 1985 Sep; 101(3):985-92. PubMed ID: 3161900
[TBL] [Abstract][Full Text] [Related]
14. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential.
Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF
Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520
[TBL] [Abstract][Full Text] [Related]
15. Interaction of heparin with rat mast cell protease 1.
Pejler G; Maccarana M
J Biol Chem; 1994 May; 269(20):14451-6. PubMed ID: 8182050
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin.
Pejler G
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):897-903. PubMed ID: 9003378
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic synthesis of glycosaminoglycan heparin.
Linhardt RJ; Dordick JS; Deangelis PL; Liu J
Semin Thromb Hemost; 2007 Jul; 33(5):453-65. PubMed ID: 17629842
[TBL] [Abstract][Full Text] [Related]
18. Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies.
Coltrini D; Rusnati M; Zoppetti G; Oreste P; Isacchi A; Caccia P; Bergonzoni L; Presta M
Eur J Biochem; 1993 May; 214(1):51-8. PubMed ID: 8508806
[TBL] [Abstract][Full Text] [Related]
19. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
[TBL] [Abstract][Full Text] [Related]
20. Bioengineered heparins and heparan sulfates.
Fu L; Suflita M; Linhardt RJ
Adv Drug Deliv Rev; 2016 Feb; 97():237-49. PubMed ID: 26555370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
